Cogent Biosciences 15min chart triggers MACD Death Cross, KDJ Death Cross, Bearish Marubozu.

Cogent Biosciences' 15-minute chart has recently triggered a MACD Death Cross, KDJ Death Cross, and a Bearish Marubozu at 08/11/2025 12:45. This indicates that the stock price has the potential to continue its downward trajectory, with a shift in momentum towards the downside and a potential for further decreases. The current market dynamics suggest that sellers are in control, and the bearish momentum is likely to persist.

Cogent Biosciences Inc (COGT) reported a quarterly adjusted loss of 53 cents per share for the quarter ended June 30, 2025, which was higher than the same quarter last year when the company reported an EPS of -59 cents [1]. The mean expectation of twelve analysts for the quarter was for a loss of 58 cents per share, with Wall Street expecting results to range from -66 cents to -46 cents per share. Reported revenue was zero, aligning with analyst expectations.

The company's reported EPS for the quarter was a loss of 64 cents, and it reported a quarterly loss of $73.53 million. Despite the financial setback, Cogent Biosciences shares have shown significant growth, rising by 67.8% this quarter and gaining 54.5% so far this year.

The mean earnings estimate of analysts had fallen by about 1.6% in the last three months, with one analyst negatively revising an earnings estimate in the last 30 days. The current average analyst rating on the shares is "buy," with 9 "strong buy" or "buy," 3 "hold," and no "sell" or "strong sell" recommendations. The average consensus recommendation for the biotechnology & medical research peer group is also "buy."

Wall Street's median 12-month price target for Cogent Biosciences Inc is $19.00, about 36.6% above its last closing price of $12.05. However, recent technical indicators suggest a bearish trend. On August 11, 2025, at 12:45, Cogent Biosciences' 15-minute chart triggered a MACD Death Cross, KDJ Death Cross, and a Bearish Marubozu. These indicators suggest that the stock price has the potential to continue its downward trajectory, with a shift in momentum towards the downside and a potential for further decreases.

References:
[1] Reuters. (2025). Cogent Biosciences Inc Reports Results for the Quarter Ended June 30. Retrieved from https://www.tradingview.com/news/reuters.com,2025:newsml_L8N3TX2BZ:0-cogent-biosciences-inc-reports-results-for-the-quarter-ended-june-30-earnings-summary/